Title : Multiplex qPCR-HRM for the detection of IMP, VIM, and NDM metallo-β-lactamase genes in clinical isolates from Costa Rica
Abstract:
Antimicrobial resistance is one of the most pressing public health challenges worldwide. In Costa Rica and across the region, carbapenem resistance has been increasingly reported, making timely and accurate detection essential for appropriate therapeutic decision-making. However, diagnostic approaches must be adapted to the local epidemiological context, as failure to do so may lead to false-negative results. This limitation was recently highlighted when conventional methods failed to detect a circulating IMP allele in Costa Rica. To address this challenge, the main circulating carbapenem resistance genes were first characterized by whole-genome sequencing (WGS). Based on these findings, we evaluated a multiplex qPCR assay coupled with high-resolution melting (HRM) analysis for the detection of VIM, IMP, and NDM. The methodology was initially validated through monoplex assays for each target and subsequently confirmed by WGS. More than 190 clinical isolates were included in the analysis. The developed assay showed high sensitivity and specificity for detecting the target genes. In addition, HRM analysis provided clear discrimination among VIM, IMP, and NDM, supporting the robustness of the multiplex design. These findings demonstrate that this strategy is a reliable and efficient molecular tool for the detection of clinically relevant carbapenemase genes in the local setting. This molecular approach represents a practical alternative to improve carbapenem resistance detection and support therapeutic decision-making in Costa Rica. Moreover, the study highlights the value of WGS for identifying locally circulating resistance determinants and guiding the optimization of molecular diagnostic tools according to the regional epidemiological context.

